Home About Us Our Mission Strategic R&D IPR applications IPR as business tools IPR advantages IPR operations IPR laws IPR for Companies IPR for R&D of company IPR for R&D Institutions IPR for Investors IPR for Individuals KPO-BPO-Outsourcing  Contact
IPR for application to Generic drug manufacturers
It is a widespread belief that a Generic drug manufacturer does not need to bother for IPR because he is after all making a business in an off-patent product.
This presumption merits rethinking.
Perhaps, Generic drug manufacturing companies could be the best benefactors of Strategic Business applications of IPR, because:
Generic drugs fall in the category of already established products and established market. This is a vastly different and far more advantageous situation than fishing out a totally new therapeutically effective molecule from unknown. Significant improvements in Generic drugs or their process can be en cashed far more easily, particularly if the company has established its own name in the market already. Thus patentable R&D has more relevance to generic drug manufacturers than new drug discoverers.
Substantial patentable improvement in Generic drug product performance by further R&D in its derivatives / structure etc. may give you a rare break in the market
Substantial improvement in process of production of an established Generic Drug may give increase in profit margins which can be exploited within a short time.